119 related articles for article (PubMed ID: 19109256)
1. A new isoform of interleukin-3 receptor {alpha} with novel differentiation activity and high affinity binding mode.
Chen J; Olsen J; Ford S; Mirza S; Walker A; Murphy JM; Young IG
J Biol Chem; 2009 Feb; 284(9):5763-73. PubMed ID: 19109256
[TBL] [Abstract][Full Text] [Related]
2. Two modes of beta-receptor recognition are mediated by distinct epitopes on mouse and human interleukin-3.
Mirza S; Chen J; Wen B; Ewens CL; Dai J; Murphy JM; Young IG
J Biol Chem; 2010 Jul; 285(29):22370-81. PubMed ID: 20472554
[TBL] [Abstract][Full Text] [Related]
3. The role of interchain heterodisulfide formation in activation of the human common beta and mouse betaIL-3 receptors.
Mirza S; Chen J; Murphy JM; Young IG
J Biol Chem; 2010 Aug; 285(32):24759-68. PubMed ID: 20516062
[TBL] [Abstract][Full Text] [Related]
4. JAK kinases overexpression promotes in vitro cell transformation.
Knoops L; Hornakova T; Royer Y; Constantinescu SN; Renauld JC
Oncogene; 2008 Mar; 27(11):1511-9. PubMed ID: 17873904
[TBL] [Abstract][Full Text] [Related]
5. Mast cells express novel functional IL-15 receptor alpha isoforms.
Bulanova E; Budagian V; Orinska Z; Krause H; Paus R; Bulfone-Paus S
J Immunol; 2003 May; 170(10):5045-55. PubMed ID: 12734349
[TBL] [Abstract][Full Text] [Related]
6. Regulation and function of protein kinase B and MAP kinase activation by the IL-5/GM-CSF/IL-3 receptor.
Dijkers PF; van Dijk TB; de Groot RP; Raaijmakers JA; Lammers JW; Koenderman L; Coffer PJ
Oncogene; 1999 Jun; 18(22):3334-42. PubMed ID: 10362354
[TBL] [Abstract][Full Text] [Related]
7. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations of ErbB4: selective loss-of-function phenotype affecting signal transduction pathways in cancer.
Tvorogov D; Sundvall M; Kurppa K; Hollmén M; Repo S; Johnson MS; Elenius K
J Biol Chem; 2009 Feb; 284(9):5582-91. PubMed ID: 19098003
[TBL] [Abstract][Full Text] [Related]
9. Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells.
Sebastián C; Serra M; Yeramian A; Serrat N; Lloberas J; Celada A
J Immunol; 2008 May; 180(9):5898-906. PubMed ID: 18424709
[TBL] [Abstract][Full Text] [Related]
10. IL-3-induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with retinoic acid receptors in an IL-3-dependent manner.
Si J; Collins SJ
Blood; 2002 Dec; 100(13):4401-9. PubMed ID: 12393611
[TBL] [Abstract][Full Text] [Related]
11. Interleukins 2 and 15 regulate Ets1 expression via ERK1/2 and MNK1 in human natural killer cells.
Grund EM; Spyropoulos DD; Watson DK; Muise-Helmericks RC
J Biol Chem; 2005 Feb; 280(6):4772-8. PubMed ID: 15563472
[TBL] [Abstract][Full Text] [Related]
12. Bivalent binding and signaling characteristics of Leridistim, a novel chimeric dual agonist of interleukin-3 and granulocyte colony-stimulating factor receptors.
Monahan JB; Hood WF; Welply JK; Shieh JJ; Polazzi JO; Li X
Exp Hematol; 2001 Apr; 29(4):416-24. PubMed ID: 11301181
[TBL] [Abstract][Full Text] [Related]
13. Interleukin (IL)-31 activates signal transducer and activator of transcription (STAT)-1, STAT-5 and extracellular signal-regulated kinase 1/2 and down-regulates IL-12p40 production in activated human macrophages.
Kasraie S; Niebuhr M; Werfel T
Allergy; 2013 Jun; 68(6):739-47. PubMed ID: 23621408
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways.
Choi SC; Kim SJ; Choi JH; Park CY; Shim WJ; Lim DS
Stem Cells Dev; 2008 Aug; 17(4):725-36. PubMed ID: 18788932
[TBL] [Abstract][Full Text] [Related]
15. The role of disulfide-linked dimerization in interleukin-3 receptor signaling and biological activity.
Le F; Stomski F; Woodcock JM; Lopez AF; Gonda TJ
J Biol Chem; 2000 Feb; 275(7):5124-30. PubMed ID: 10671557
[TBL] [Abstract][Full Text] [Related]
16. Function and signal transduction mediated by the interleukin 3 receptor system in hematopoiesis.
Hara T; Miyajima A
Stem Cells; 1996 Nov; 14(6):605-18. PubMed ID: 8948019
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
[TBL] [Abstract][Full Text] [Related]
18. Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A.
Sacco A; Morcavallo A; Pandini G; Vigneri R; Belfiore A
Endocrinology; 2009 Aug; 150(8):3594-602. PubMed ID: 19443570
[TBL] [Abstract][Full Text] [Related]
19. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
Yu WM; Hawley TS; Hawley RG; Qu CK
Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous activation of JAK1 and JAK2 confers IL-3 independent growth on Ba/F3 pro-B cells.
Huang HM; Lin YL; Chen CH; Chang TW
J Cell Biochem; 2005 Oct; 96(2):361-75. PubMed ID: 15988755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
